Skip to content
Search

Latest Stories

LloydsPharmacy partners with Ecrebo to design bespoke offers for its customers

LloydsPharmacy says is has launched a partnership with technology company Ecrebo to bring what it called 'bespoke offers and savings' to its 2.5 million customers across the UK.

The second largest pharmacy chain in the UK will use Ecrebo’s marketing solutions to help drive targeted engagement and bring a range of benefits to customers who visit its stores every month.


LloydsPharmacy is will also be looking to leverage customer interactions and data so it is able to communicate with its customers more quickly and effectively. It will add personalised offers and messages to paper receipts issued at over 1,100 locations nationwide.

The partnership between the two companies was launched earlier this month after a successful trial of Ecrebo’s light-touch POS software technology in 250 LloydsPharmacy stores.

LlyodsPharmacy also shared that the launch was done to acknowledge the changing shopping behaviour and customer needs post pandemic.

Kyle Rowe, chief marketing and digital officer at McKesson UK, parent company to LloydsPharmacy, said: "LloydsPharmacy is going through an exciting period of transformation and our customers are at the heart of this. Our partnership with Ecrebo is all about better understanding their needs so we can provide a one-to-one shopping experience, rewarding them with offers that are tailored to their shopping tendencies. Ecrebo’s software enables us to reach every shopper with bespoke savings whilst giving us the flexibility to target coupons specific to a single pharmacy or our entire estate.”

Bespoke offers for customers include free giveaways and money off coupons to spend instore and online, he shared.

“These offers will be based on what’s in their basket and printed at the bottom of their receipt. When the receipt is handed to the customer, their offer will be read aloud by the colleague serving them, helping to drive thousands of unique conversations every day in the 1,100 pharmacies utilising the software.”

David Buckingham, CEO at Ecrebo, commented: “It’s always rewarding when a prestigious retailer signs a new partnership agreement with Ecrebo. LloydsPharmacy customers will receive regular, relevant targeted offers to encourage them back into store to buy the things they want and need from their local pharmacy.

"This is the first major pharmacy chain in the UK to adopt this technology and the results so far have been really encouraging. We’re looking forward to building this relationship further and delivering more value over the coming months and years.”

More For You

After Lagevrio, Paxlovid to be deleted from Part VIIIC of Drug Tariff

Paxlovid is intended for patients at high risk of severe COVID-19 outcomes.

gettyimages

Pharmacies to pay full NHS list price for Paxlovid from May 2025

Community Pharmacy England (CPE) has informed pharmacies that the government’s stockpile of COVID-19 antiviral medicine,Paxlovid, will expire on 31 May 2025, with the final delivery of ordered stock due by 30 April 2025.

Paxlovid (Nirmatrelvir 150mg tablets and Ritonavir 100mg tablets) will be removed from Part VIIIC of the May 2025 Drug Tariff, following confirmation from NHS England (NHSE) that all remaining government-procured supplies will expire at the end of May.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
​Pope Francis

Pope Francis at the Vatican on December 4, 2024.

Photo by FILIPPO MONTEFORTE/AFP via Getty Images

His Holiness Mahant Swami Maharaj offers condolences to Catholic community following Pope Francis' passing

His Holiness Mahant Swami Maharaj, the spiritual leader and president of the Bochasanwasi Akshar Purushottam Swaminarayan Sanstha (BAPS), has expressed heartfelt condolences to the Catholic community worldwide following the passing of Pope Francis on Monday.

In a formal letter addressed to the members of the Roman Catholic Church, Mahant Swami Maharaj conveyed the deep sorrow of the BAPS Swaminarayan Hindu fellowship, acknowledging the Pope's passing as “a profound loss to the Catholic community and Christians around the world.”

Keep ReadingShow less
Pharmacies in Northern Ireland distribute free booklets to raise cancer awareness

Dr Anna Cullen, Public Health Registrar at the Public Health Agency and Clare Conroy, Community Pharmacist from Meigh Pharmacy in Co Down.

Photo credit: Community Pharmacy Northern Ireland

Pharmacies in Northern Ireland help raise cancer awareness

Community pharmacies across Northern Ireland are distributing a free information booklet to help raise public awareness of the signs and symptoms of cancer and promote early diagnosis.

The initiative is part of the ‘Be Cancer Aware’ campaign, which has been running in pharmacies since April and will continue through May as part of the Living Well service.

Keep ReadingShow less
CPE invites pharmacy owners to share their views on new CPCF funding settlement

What do you think should be the next priority for the Government?

gettyimages

Pharmacy owners asked to share their views on new CPCF arrangements

Community Pharmacy England (CPE) is urging pharmacy owners to share their views on the new Community Pharmacy Contractual Framework (CPCF) funding settlement ahead of its next full Committee meeting, scheduled for 30 April–1 May.

The Committee said it had agreed to the settlement "reluctantly," acknowledging that it represents a significant shift after years of real-terms funding cuts, while admitting that it’s “still not sufficient to match the continued scale of pressures facing pharmacy businesses.”

Keep ReadingShow less